Medicortex Finland Oyj

Medicortex Finland Oyj is a biotechnology company dedicated to developing diagnostics and treatments for acute neurodegenerative conditions, including traumatic brain injury (TBI) and concussion. The company is currently focusing on the development of a rapid test, based on a proprietary biomarker, for detection of TBI and concussion. Medicortex was founded by Dr. Adrian Harel in Turku, Finland, in 2014 and it operates as a public limited company. Dr. Harel has a track record in business management and leadership of early-stage biotechnology companies- Kuvaus suomeksi: Medicortex Finland Oyj on bioteknologian alan yritys, joka on keskittynyt parantamaan tapaturmaisten aivovammojen (TBI) diagnostiikkaa ja hoitoa. Yrityksen nykyinen painopiste on kehittää biomerkkiaineisiin perustuvaa diagnostiikkaa, jolla pystytään arvioimaan aivovamman laajuutta ja vaikeusastetta.